| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.12 | 0.6 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.11 | 0.6 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.11 | 0.6 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.1 | 0.6 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.099 | 0.02 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.096 | 0.6 |